PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.31%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
2.91%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
7.71%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
7.71%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
4.16%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
4.15%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
4.15%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3141.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.83%
10Y revenue/share CAGR under 50% of 3141.T's 152.04%. Michael Burry would suspect a lasting competitive disadvantage.
51.99%
5Y revenue/share CAGR at 75-90% of 3141.T's 61.98%. Bill Ackman would encourage strategies to match competitor’s pace.
23.42%
3Y revenue/share CAGR at 75-90% of 3141.T's 29.67%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.42%
Below 50% of 3141.T's 161.82%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
33.73%
5Y net income/share CAGR at 50-75% of 3141.T's 61.79%. Martin Whitman might see a shortfall in operational efficiency or brand power.
23.99%
3Y net income/share CAGR 50-75% of 3141.T's 45.87%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
167.66%
10Y equity/share CAGR at 50-75% of 3141.T's 273.55%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
110.15%
5Y equity/share CAGR 1.25-1.5x 3141.T's 74.35%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
52.73%
3Y equity/share CAGR 1.25-1.5x 3141.T's 40.73%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.78%
3Y dividend/share CAGR of 77.78% while 3141.T is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
14.05%
AR growth well above 3141.T's 6.06%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.11%
Inventory is declining while 3141.T stands at 8.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.78%
Negative asset growth while 3141.T invests at 2.88%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.01%
BV/share growth above 1.5x 3141.T's 0.99%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-7.70%
We’re deleveraging while 3141.T stands at 20.85%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.88%
SG&A growth well above 3141.T's 1.46%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.